Prehypertension: epidemiology, consequences and treatment (Q37633929)

21 August 2017

1 reference

title

Prehypertension: epidemiology, consequences and treatment (English)

1 reference

21 August 2017

1 reference

Suzanne Oparil

1 reference

21 August 2017

Eduardo Pimenta

1 reference

21 August 2017

language of work or name

English

0 references

publication date

17 November 2009

1 reference

Nature Reviews Nephrology

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

21-30

1 reference

The metabolic syndrome and chronic kidney disease in U.S. adults

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prehypertension during young adulthood and coronary calcium later in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

2007 Guidelines for the Management of Arterial Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prehypertension and mortality in a nationally representative cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prehypertension and cardiovascular disease risk in the Women's Health Initiative

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Elevation of C-reactive protein in people with prehypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Relationships between age, blood pressure, and retinal vessel diameters in an older population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Retinal Vessel Diameters and Their Associations with Age and Blood Pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Retinal vessel diameters and risk of hypertension: the Rotterdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Serum uric acid is associated with microalbuminuria in prehypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Implications of persistent prehypertension for ageing-related changes in left ventricular geometry and function: the MONICA/KORA Augsburg study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Impact of high-normal blood pressure on the risk of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Is prehypertension a risk factor for cardiovascular diseases?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Cardiovascular Outcome in Relation to Progression to Hypertension in the Copenhagen MONICA Cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Clinical effect of lifestyle modification on cardiovascular risk in prehypertensives: PREHIPER I study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Management of prehypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prehypertension revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Decline in cardiovascular mortality in North Karelia and other parts of Finland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Feasibility of treating prehypertension with an angiotensin-receptor blocker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Pharmacotherapy for prehypertension--mission accomplished?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.191

Hypertension awareness, treatment, and control--continued disparities in adults: United States, 2005-2006

31 March 2020

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Blood pressure as a cardiovascular risk factor: prevention and treatment

1 reference

12 December 2020

Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases.

1 reference

12 December 2020

Decline in cardiovascular mortality in North Karelia and other parts of Finland

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.191

1 reference

21 August 2017

1 reference